
### [NCIT:C3049](http://purl.obolibrary.org/obo/NCIT_C3049)
**Label:** Ganglioneuroma

**Subclasses:** [NCIT:C5427](http://purl.obolibrary.org/obo/NCIT_C5427) (Retroperitoneal Ganglioneuroma), [NCIT:C6632](http://purl.obolibrary.org/obo/NCIT_C6632) (Mediastinal Ganglioneuroma), [NCIT:C96514](http://purl.obolibrary.org/obo/NCIT_C96514) (Colorectal Ganglioneuroma), [NCIT:C7042](http://purl.obolibrary.org/obo/NCIT_C7042) (Colon Ganglioneuroma), [NCIT:C4481](http://purl.obolibrary.org/obo/NCIT_C4481) (Cutaneous Ganglioneuroma), [NCIT:C66804](http://purl.obolibrary.org/obo/NCIT_C66804) (Ganglioneuromatosis), 

**Class expressions from DL-Learner:**

- [UBERON:0003693](http://purl.obolibrary.org/obo/UBERON_0003693) (retroperitoneal space) 58.33%
- [UBERON:0001155](http://purl.obolibrary.org/obo/UBERON_0001155) (colon) 58.33%
- [NCIT:C47826](http://purl.obolibrary.org/obo/NCIT_C47826) (Diffuse Lesion) 58.33%
- [NCIT:C42084](http://purl.obolibrary.org/obo/NCIT_C42084) (Neoplastic Mature Ganglion Cell) 58.33%
- [NCIT:C42063](http://purl.obolibrary.org/obo/NCIT_C42063) (Schwannian Stroma Predominant Component of the Tumor Volume) 58.33%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 58.33%
- Thing 51.99%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 43.69%
- [NCIT:C42062](http://purl.obolibrary.org/obo/NCIT_C42062) (Schwannian Stroma More than 50 Percent of the Tumor Volume) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 43.69%


